ARCA biopharma, Inc. (ABIO)
Company Info
ISIN | US00211Y5069 |
---|---|
CUSIP | 00211Y506 |
Sector | Healthcare |
Industry | Biotechnology |
Trading Data
Previous Close | $2.50 |
---|---|
Year Range | $1.77 - $3.74 |
EMA (50) | $2.35 |
EMA (200) | $2.52 |
Average Volume | $74.07K |
Market Capitalization | $36.03M |
ABIOShare Price Chart
Click Calculate to get results
ABIOPerformance
The chart shows the growth of $10,000 invested in ARCA biopharma, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10 for a total return of roughly -99.90%. All prices are adjusted for splits and dividends.
ABIOReturns in periods
Period | Return | Benchmark |
---|---|---|
1M | 3.31% | -8.16% |
YTD | 16.28% | -19.88% |
6M | 12.11% | -20.21% |
1Y | -30.17% | -11.00% |
5Y | -43.49% | 9.57% |
10Y | -39.27% | 10.88% |
ABIOMonthly Returns Heatmap
Click Calculate to get results
ABIODividend History
ARCA biopharma, Inc. doesn't pay dividends
ABIODrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ABIOWorst Drawdowns
The table below shows the maximum drawdowns of the ARCA biopharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the ARCA biopharma, Inc. is 99.97%, recorded on Jan 28, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.97% | Mar 29, 2010 | 2982 | Jan 28, 2022 | — | — | — |
-23.92% | Jan 12, 2010 | 50 | Mar 24, 2010 | 2 | Mar 26, 2010 | 52 |
-1.22% | Jan 5, 2010 | 1 | Jan 5, 2010 | 2 | Jan 7, 2010 | 3 |
ABIOVolatility Chart
Current ARCA biopharma, Inc. volatility is 39.62%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.
Portfolios with ARCA biopharma, Inc.
Loading data...